Pathogenic anti-nucleosome antibodies

Lupus

Volumn 17, Issue 5 SPEC. ISS., 2008, Pages 431-436

  Muller, Sylviane ^a   Dieker, J ^a   Tincani, A ^b   Meroni, P L ^c  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY; EPITOPE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HISTONE; NEPHRITOGENIC ANTIGEN; NUCLEOSOME ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; APOPTOSIS; AUTOIMMUNITY; HUMAN; IMMUNE SYSTEM; IMMUNOGENICITY; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 44849110309     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308090030     Document Type: Review

References (72)

1. Desai-Metha, A, Mao, C, Rajagopalan, S, Robinson, T, Datta, SK. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995; 95: 531-541.
2. Kaliyaperumal, A, Mohan, C, Wu, W, Datta, SK. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med 1996; 183: 2459-2469.
3. Voll, RE, Roth, AR, Girkontaite, I, et al. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum 1997; 40: 2162-2171.
4. Lu, L, Kaliyaperumal, A, Boumpas, DT, Datta, SK. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J Clin Invest 1999; 104: 345-355.
5. Burlingame, RW, Rubin, RL, Balderas, RS, Theofilopoulos, AN. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 1993; 91: 1687-1696.
6. Amoura, Z, Chabre, H, Koutouzov, S, et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994; 37: 1684-1688.
7. Fournié, GJ. Circulating DNA and lupus nephritis. Kidney Int 1988; 33: 487-497.
8. Rumore, PM, Steinman, CR. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 1990; 86: 69-74.
9. Burlingame, RW. Boey, Ml, Starkebaum, G, Rubin, RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994; 94: 184-192.
10. Williams, RC, Malone, CC, Meyers, C, Decker, P, Muller, S. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7. J Rheumatol 2001; 28: 81-94.
11. Schmiedeke, T, Stoeckl, F, Muller, S, et al. Glomerular immune deposits in murine lupus models may contain histones. Clin Exp Immunol 1992; 90: 453-458.
12. van Bruggen, MCJ, Kramers, C, Walgreen, B, et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 1997; 12: 57-66.
13. Elouaai, F, Lule, J, Benoist, H, et al. Autoimmunity to histones, ubiquitin and ubiquitinated H2A in NZB x NZW and MRL-lpr/lpr lupus mice. Anti-histone antibodies are concentrated in glomerular eluates of lupus mice. Nephrol Dial Transplant 1994; 9: 362-366.
14. Kramers, C, Hylkema, MN, van Bruggen, MCJ, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994; 94: 568-577.
15. Lefkowith, JB, Gilkeson, GS. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 1996; 39: 894-903.
16. van Bruggen, MCJ, Kramers, C, Hylkema, MN, Smeenk, RJT, Berden, JHM. Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin Exp Immunol 1996; 105: 132-139.
17. Grootscholten, C, Van Bruggen, MCJ, Van der Pijl, JW, et al. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum 2003; 48: 1355-1362.
18. Amoura, Z, Piette, JC, Bach, JF, Koutouzov, S. The key role of nucleosomes in lupus. Arthritis Rheum 1999; 42: 833-843.
19. Dieker, JWC, van der Vlag, J, Berden, JHM. Triggers for antichromatin autoantibody production in SLE. Lupus 2002; 11: 856-864.
20. Koutouzov, S, Jeronimo, AL, Campos, H, Amoura, Z. Nucleosomes in the pathogenesis of systemic lupus erythematosus. Rheum Dis Clin N Am 2004; 30: 529-558.
21. Burlingame, RW. Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies. Clin Appl Immunol Rev 2004; 4: 351-366.
22. Decker, P. Nucleosome autoantibodies. Clin Chim Acta 2006; 366: 48-60.
23. Herrmann, M, Zoller, OM, Hagenhofer, M, Voll, R, Kalden, JR. What triggers anti-dsDNA antibodies? Mol Biol Rep 1996; 23: 265-267.
24. Ren, Y, Tang, J, Mok, MY, Chan, AWK, Wu, A, Lau, CS. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 2888-2897.
25. Licht, R, Dieker, JW, Jacobs, CW, Tax, WJ, Berden, JH. Decreased phagocytosis of apoptotic cells in diseased SLE mice. J Autoimmun 2004; 22: 139-145.
26. Bijl, M, Reefman, E, Horst, G, Limburg, PC, Kallenberg, CG. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis 2006; 65: 57-63.
27. Gaipl, U, Kuhn, A, Sheriff, A, et al. Inefficient clearance of dying cells and autoreactivity. Curr Top Microbiol Immunol 2006; 305: 161-176.
28. Stollar, BD, Ward, M. Rabbit antibodies to histone fractions as specific reagents for preparative and comparative studies. J Biol Chem 1970; 245: 1261-1269.
29. Romani, M, Vidali, G, Tahourdin, CS, Bustin, M. Solid phase radioimmunoassay for chromosomal components. J Biol Chem 1980; 255: 468-474.
30. Einck, L, Dibble, R, Frado, LY, Woodcock, CL. Nucleosomes as antigens. Characterization of determinants and cross- reactivity. Exp Cell Res 1982; 139: 101-110.
31. Muller, S, Bonnier, D, Thiry, M, Van Regenmortel, MHV. Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides. Int Arch Allergy Appl Immunol 1989; 89: 288-296.
32. Atanassov, C, Briand, JP, Bonnier, D, Van Regenmortel, MHV, Muller, S. New Zealand white rabbits immunized with RNA-complexed total histones develop an autoimmune-like response. Clin Exp Immunol 1991; 86: 124-133.
33. + T cells from (NZBxNZW)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C-terminus of histone H3. J Immunol 2003; 171: 636-644.
34. Patry, YC, Trewick, DC, Gregoire, M, et al. Rats injected with syngenic rat apoptotic neutrophils develop antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 2001; 12: 1764-1768.
35. Mevorach, D, Zhou, JL, Song, X, Elkon, KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998; 188: 387-392.
36. Bondanza, A, Zimmermann, VS, Dell'Antonio, G, et al. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum 2004; 50: 1549-1560.
37. Georgiev, M, Agle, LM, Chu, JL, Elkon, KB, Ashany, D. Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression. Arthritis Rheum 2005; 52: 225-238.
38. Datta, SK, Zhang, L, Xu, L. T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens. J Mol Med 2005; 83: 267-278.
39. Levine, JS, Subang, R, Nasr, SH, et al. Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus. J Immunol 2006; 177: 6504-6516.
40. Fadok, VA, Bratton, DL, Konowal, A, Freed, PW, Westcott, JY, Henson, PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
41. Koh, JS, Wang, Z, Levine, JS. Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus. J Immunol 2000; 165: 4190-4201.
42. Fan, H, Longacre, A, Meng, F, et al. Cytokine dysregulation induced by apoptotic cells is a shared characteristic of macrophages from non-obese diabetic and systemic lupus erythematosus-prone mice. J Immunol 2004; 172: 4834-4843.
43. Suer, W, Dähnrich, C, Schlumberger, W, Ströcker, W. Autoantibodies in SLE but not in scleroderma react with protein-stripped nucleosomes. J Autoimmun 2004; 22: 325-334.
44. Bruns, A, Blass, S, Hausdorf, G, Burmester, GR, Hiepe, F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 2307-2315.
45. Villalta, D, Tozzoli, R, Bizzaro, N, Tonutti, E, Ghirardello, A, Doria, A. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays. Ann NY Acad Sci 2005; 1050: 167-184.
46. Su, Y, Jia, R-L, Han, L, Li, Z-G. Role of antinucleosome antibody in the diagnosis of systemic lupus erythematosus. Clin Immunol 2007; 122: 115-120.
47. Gomez-Puerta, JA, Burlingame, RW, Cervera, R. Anti-chromatin (anti-nucleosome) antibodies. Lupus 2006; 15: 408-411.
48. Cervera, R, Viñas, O, Ramos-Casals, M, et al. Antichromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 2003; 62: 431-434.
49. Gutierrez-Adrianzen, OA, Koutouzov, S, Mota, RM, Das Chagas Medeiros, MM, Bach, JF, de Holanda Campos, H. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies. J Rheum 2006; 33: 1538-1544.
50. Ng, KP, Manson, JJ, Rahman, A, Isenberg, DA. Association of anti-nucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Rheum (Arthritis Care Res.) 2006; 55: 900-904.
51. Amoura, Z, Koutouzov, A, Chabre, H, et al. Presence of antinucleosome antibodies in a restricted set of connective tissue diseases. Arthritis Rheum 2000; 43: 76-84.
52. Simón, JA, Rojas-Serrano, J, Cabiedes, J, Alcocer-Varela, J. Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome. Lupus 2004; 13: 177-181.
53. Andreoli, L, Pregnolato, F, Burlingame, RW, et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? J Autoimmun 2008; 30: 51-57.
54. Manfredi, AA, Rovere, P, Galati, G, et al. Apoptotic cell clearance in systemic lupus erythematosus. I. opsonization by antiphospholipid antibodies. Arthritis Rheum 1998; 41: 205-214.
55. Manfredi, AA, Rovere, P, Heltai, S, et al. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis Rheum 1998; 41: 215-223.
56. Rivadeneyra-Espinoza, L, Ruiz-Argüelles, A. Cell-penetrating anti-native DNA antibodies trigger apoptosis through both the neglect and programmed pathways. J Autoimmun 2006; 26: 52-56.
57. Yanase, K, Madaio, MP. Nuclear localizing anti-DNA antibodies enter cells via caveoli and modulate expression of caveolin and p53. J Autoimmun 2005; 24: 145-151.
58. Alberdi, F, Dadone, J, Ryazanov, A, Isenberg, DA, Ravirajan, C, Reichlin, M. Cross-reaction of lupus anti-dsDNA antibodies with protein translation factor EF-2. Clin Immunol 2001; 98: 293-300.
59. Qing, X, Zavadil, J, Crosby, MB, et al. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 2006; 54: 2198-2210.
60. Radic, M, Marion, T, Monestier, M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004; 172: 6692-6700.
61. Frisoni, L, McPhie, L, Colonna, L, et al. Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens: a novel pathogenic pathway for autoimmunity? J Immunol 2005; 175: 2692-2701.
62. Sarmiento, LF, Muñoz, LE, Chirinos, P, Bianco, NE, Zabaleta-Lanz, ME. Opsonization by anti-dsDNA antibodies of apoptotic cells in systemic lupus erythematosus. Autoimmunity 2007; 40: 337-339.
63. Reefman, E, Horst, G, Nijk, MT, Limburg, PC. Kallenberg, CG, Bijl, M. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism. Arthritis Rheum 2007; 56: 3399-3411.
64. Leadbetter, EA, Rifkin, IR, Hohlbaum, AM, Beaudette, BC, Shlomchik, MJ, Marshak-Rothstein, A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416: 603-607.
65. Herlands, RA, William, J, Hershberg, U, Shlomchik, MJ. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur J Immunol 2007; 37: 3339-3351.
66. Boulé, MW, Broughton, C, Mackay, F, Akira, S, Marshak-Rothstein, A, Rifkin, IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004; 199: 1631-1640.
67. Bell, CW, Jiang, W, Reich, CF, Pisetsky, DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006; 291: C1318-C1325.
68. Tian, J, Avalos, AM, Mao, SY, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8: 487-496.
69. van Bavel, CC, van der Viag, J, Berden, JH. Glomerular binding of anti-dsDNA autoantibodies: the dispute resolved? Kidney Int 2007; 71: 600-601.
70. Kalaaji, M, Mortensen, E, Jørgensen, L, Olsen, R, Rekvig, OP. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 2006; 168: 1779-1792.
71. Kalaaji, M, Fenton, KA, Mortensen, ES, et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 2007; 71: 664-672.
72. Mjelle, JE, Rekvig, OP, Fenton, KA. Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis. Ann Rheum Dis 2007; 66: 1661-1668.